Amylyx Pharmaceuticals (AMLX) EPS (Basic) (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly EPS (Basic) of -$0.82 for Q1 2026, down 96.33% year-over-year from -$22.39 in Q1 2025, and down 135.73% quarter-over-quarter from -$0.35 in Q4 2025.
Amylyx Pharmaceuticals (AMLX) EPS (Basic) (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.82 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 96.33% year-over-year to -$0.82; the TTM figure through Mar 2026 stood at -$1.81 (up 0.61% YoY), while the FY2025 annual figure was -$1.53, up 56.31% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.82, down from -$0.35 in the prior quarter.
- The five-year high for EPS (Basic) was $0.37 in Q4 2024, with the low at -$1.75 in Q1 2024.
- The 5-year median for EPS (Basic) is -$0.46 (2025), against an average of -$0.52.
- Peak annual rise in EPS (Basic) reached 833.27% in 2024, while the deepest fall reached 7525.45% in 2024.
- Amylyx Pharmaceuticals' EPS (Basic) stood at -$0.75 in 2022, then jumped by 105.36% to $0.04 in 2023, then surged by 833.27% to $0.37 in 2024, then slumped by 193.21% to -$0.35 in 2025, then sank by 135.73% to -$0.82 in 2026.
- Business Quant data shows AMLX's EPS (Basic) at -$0.82 in Q1 2026, -$0.35 in Q4 2025, and -$0.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 1.65 |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 1.43 |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | -0.02 |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 0.11 |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - | -1.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 |
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | -1.07 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.75 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -4.30 |
| Sep 30, 2021 | -3.42 |